A meeting of the Board of Directors of Manor Estates and Industries Limited was held on August 06, 2026, commencing at 04:00 PM and concluding at 06:00 PM at the company's registered office in Medak, Telangana.

The Board approved and took on record the following items:

1. Financial Results and Reports

  • Approved the Un-audited financial results of the Company for the quarter ended June 30, 2026.
  • Taken on record the Auditor's Limited review report on the financial statements for the quarter ended June 30, 2026.
  • Taken on record the Internal Audit report for the financial year 2025-26.

2. Annual General Meeting (AGM)

  • Fixed the date of the 34th Annual General Meeting (AGM) to be held on September 30, 2026.
  • Approved the Directors' Report for the financial year ended March 31, 2026.
  • Approved the Notice calling the 34th Annual General Meeting.

3. AGM Arrangements

  • Approved the appointment of M/s Kashinath Sahu & Co., Practising Company Secretaries (Firm No. 4807), as the Scrutinizer for E-voting and Voting by Ballot at the 34th AGM.

4. Director Re-appointment

  • Approved the re-appointment of Ms. Nalini Agarwal (DIN: 07164298) as a Director of the Company, liable to retire by rotation under Section 152 of the Companies Act, 2013. This re-appointment is subject to the approval of shareholders at the 34th AGM.

Financial Highlights (Quarter Ended June 30, 2026)

The unaudited standalone financial results for Q1 FY27 were reviewed by the statutory auditors, Nataraja Iyer & Co.

Profit & Loss Statement (Rs. in Lakhs)

  • Total Income: ₹0.25
  • Total Expenses: ₹17.40
  • Profit/(Loss) Before Tax: (₹17.15)
  • Tax Expense: ₹0.09 (comprising Current Tax of ₹0.00 and Tax Expense of Earlier Years of ₹0.09)
  • Profit/(Loss) for the Period (Net Loss): (₹17.23)
  • Earnings Per Share (EPS) (not annualised): (₹0.21) [Basic and Diluted]

Balance Sheet Position (As of June 30, 2026)

  • Paid-up Equity Share Capital: ₹823.50 Lakhs (Face Value ₹10/- each)
  • Reserves & Surplus: (₹1,135.57 Lakhs)
  • Total Shareholders' Funds: (₹312.07 Lakhs)
  • Total Assets: ₹305.84 Lakhs
  • Total Liabilities: ₹305.84 Lakhs

Cash Flow (Q1 FY27)

  • Net Cash Used in Operating Activities: (₹6.78 Lakhs)
  • Net Cash Used in Investing Activities: (₹9.65 Lakhs)
  • Net Cash from Financing Activities: ₹7.62 Lakhs
  • Net Decrease in Cash and Cash Equivalents: (₹2.24 Lakhs)
  • Cash and Cash Equivalents at Period End: ₹2.27 Lakhs

Details of Director Re-appointment (Annexure-A)

The disclosure for the re-appointment of Ms. Nalini Agarwal was provided as per SEBI LODR Regulations and Circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123.

  • Reason for Change: Retirement by rotation.
  • Proposed Term: Re-appointment subject to shareholder approval at the 34th AGM on September 30, 2026.
  • Brief Profile: Ms. Agarwal has expertise, knowledge, and acumen in legal matters beneficial to the Company.
  • Relationship Disclosure: She is the spouse of Mr. Rishabh Agarwal.

This intimation was made pursuant to Regulation 30 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and has been uploaded on the company's website (www.meilmedak.in).